Shreyas Kalantri/X
Aug 4, 2025, 14:54
Shreyas Kalantri: Engaging Insights on VTE Management
Shreyas Kalantri, Hematology and Oncology Chief Fellow at UofL Brown Cancer Center, shares an insight on VTE management on X:
”VTE management doesn’t stop at anticoagulation. Here are pearls to sharpen your heme boards prep and clinical instincts.
1. Thrombus extension after starting anticoagulation ≠ treatment failure.
Asymptomatic progression can happen in the first 1–2 weeks. No need to escalate therapy unless clinically indicated.”
Dr. Shreyas Kalantri offers engaging and thought‑provoking insights to help you refine and master your clinical reasoning—well worth following.
Stay tuned with Hemostasis Today.
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin
-
Jan 12, 2026, 15:07Aaron Iding and Colleagues on Additional Oxerutin Link to DVT
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
